Cite
HARVARD Citation
Megías-Vericat, J. et al. (2021). Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients. Thrombosis research. pp. 99-105. [Online].